[Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
Maksimenko
A V
AV
Tishchenko
E G
EG
Petrova
M L
ML
Golubykh
V L
VL
D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D004359:Drug Therapy, Combination; D005340:Fibrinogen / Q000737:chemistry*; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*
D005340:Fibrinogen; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Effekty potentsirovaniia i bystrodeĭstviia na modeli venoznogo tromboza u sobak pri kominirovannom vvedenii tkanevogo aktivatora plazminogena i modifitsirovannoĭ fibrinogenom urokinazy.